Register Now - Beyond Recruitment: The Future of Patient Site Engagement in Oncology Clinical Trials
|Articles|June 15, 2015

Comprehend Systems Launches ClinOps Solution

Comprehend Systems, a clinical software solutions provider, announced the launch of Continuous Quality for ClinOps.

Comprehend Systems, a clinical software solutions provider, announced the launch of Continuous Quality for ClinOps, a solution that enables clinical operations to unify and analyze its data and automates alerts and collaboration across executives, teams and contract research organizations (CROs). 

The solution automates the continuous quality lifecycle, features include:

  • Analytics and Visualizations  inform your decision-making and collaboration processes on site and operational performance, safety, efficacy and compliance

  •  Filtering enables end users to remove redundant or unwanted data from the info stream to facilitate exploration and cohort analysis

  •  Click-through enables the user to broaden or narrow their exploration from portfolio views down to granular study data even with unique data models across studies

  • Forecasts for key indicators that predict future outcomes based on historic facts

  • Cross Study Benchmarking uses current similar and past trials to inform decisions on current trials

  • Monitoring system tracks trends and allows user-driven thresholds to raise events in the system.  Early warnings enable ClinOps leaders to take preventative action

  • Collaboration provides decentralized users with simultaneous views of analytics and ability to create data-driven tasks and workflows

  •  Alerts and Notifications of events can be in app or email or both

  •  Audit trails allows full auditability of system state from any point in time, including user activity  for compliance and report configuration for decision history

 

Read the full release.


Related to this article

Closing the Community Access Gap: Q&A with Kent Thoelke, Paradigm Health
In this Q&A, Kent Thoelke, CEO of Paradigm Health, discusses why participation gaps in community and rural settings come down to both patient cost barriers and site infrastructure, how legacy workflows weigh on community clinics, and what policy and technology changes it would take to make clinical research a real care option for more patients.
© Grispb - © Grispb - stock.adobe.com
Mistral and OpenAI produced identical overall eligibility labels across 200 synthetic patient-study assessments, with criterion-level disagreements concentrated in inclusion criteria where models switch between “Uncertain” and “Not included” when records lack sufficient evidence, so model choice should be driven by deployment architecture, control, and cost rather than assumed interchangeability.
The Human Side of Clinical Trials: Before Burden Becomes Risk, Capturing Friction in Real Time
In Episode 4 of The Human Side of Clinical Trials, host Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., speaks with Jason Riis, PhD, CEO and chief behavioral scientist at Behavioralize, about how capturing friction closer to the moment it happens can reveal unclear instructions, technology friction, and workarounds that retrospective surveys and debriefs tend to miss.